Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

OA Prevalence Primarily on the Rise

Arthritis & Rheumatology  |  June 29, 2022

Background & Objectives

Worldwide, osteoarthritis (OA) is a highly prevalent, chronic joint disease that causes pain, disability and loss of function. Global trends demonstrated an increase of more than 100% in years lived with disability due to OA from 1990 to 2019. However, no nonsurgical intervention exists to prevent, halt or even delay OA progression. Moreover, available medications, such as nonsteroidal anti-inflammatory drugs, have been associated with a clinically relevant 50–100% increase in the risk of myocardial infarction or death from cardiovascular causes. The public, healthcare providers and policymakers should be aware of the heavy burden of OA.

The prevalence of OA varies by the joints involved. The knee is the most frequently affected joint, followed by the hand and the hip. Knee, hip and hand OA each have a distinct effect on overall health. For example, knee and hip OA, but not hand OA, are associated with an increased risk of cardiovascular and all-cause premature mortality.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In addition, OA has been shown to have different pathologic mechanisms in different joints. OA of the hand has been associated with systemic inflammation, while OA of the knee and OA of the hip have been correlated with excessive joint load and injury. Taken together, these findings indicate a need for documentation regarding the burden of site-specific OA, which remains scarce in the literature.

Long et al. set out to estimate systematic and anatomic, site-specific, age-standardized prevalence rates of OA and analyze the secular trends at global, regional and national levels.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Methods

Data were derived from the Global Burden of Disease Study 2019. Age-standardized prevalence rates and their estimated annual percentage changes were used to describe the secular trends of OA according to age group, sex, region, country and territory, as well as the joints involved.

Results

From 1990 to 2019, the prevalence of OA increased globally by 113.25%, from 247.51 million in 1990 to 527.81 million in 2019. Age-standardized prevalence rates were 6,173.38 per 100,000 persons in 1990 and 6,348.25 per 100,000 persons in 2019, with an estimated annual percentage change of 0.12% (95% confidence interval [95% CI] 0.11%, 0.14%). The age-standardized prevalence rates of OA increased for the knee, hip and other joints, but decreased for the hand, with estimated annual percentage changes of 0.32 (95%CI 0.29, 0.34), 0.28 (95% CI 0.26, 0.31), 0.18 (95% CI 0.18, 0.19) and −0.36 (95% CI −0.38, −0.33), respectively. OA prevalence increased with age and revealed female preponderance, geographic diversity and disparity with regard to anatomic site. OA of the knee contributed the most to the overall burden, while OA of the hip had the highest estimated annual percentage changes in most regions.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:Arthritis & RheumatologydisabilityOsteoarthritisosteoarthritis (OA)PrevalenceResearch

Related Articles

    Exercise Therapy Recommended to Manage Knee Osteoarthritis

    July 12, 2016

    The benefits of exercise therapy for individuals with knee osteoarthritis (OA) are well known. The ACR strongly recommends both aquatic exercise and land-based aerobic and resistance exercise for managing knee OA.1 A recent Cochrane systematic review and meta-analysis concluded that high-quality evidence supports the use of exercise to reduce pain and improve physical function and…

    Changing Our Thinking on Osteoarthritis

    March 1, 2010

    It’s time we changed our thinking on osteoarthritis

    Insights on the Diagnosis & Treatment of Low Back & Hip Pain

    March 19, 2019

    CHICAGO—Two experts presented insights on the diagnosis and treatment of low back and hip pain, including a refresher course on the mechanical structures involved, in Anatomy in a Day: Demystifying Low Back Pain and Lateral Hip Pain: New Patho-Anatomical Perspectives, a session at the 2018 ACR/ARHP Annual Meeting. Low Back Pain Avoid using such terms…

    New Research Shows Knee Osteoarthritis Prevalence Is Rising

    September 20, 2018

    Studies highlighting the large numbers of people affected by knee osteoarthritis (OA) point to what clinicians who treat knee OA have been seeing for the past few decades: a substantial increase in the prevalence of knee OA in the U.S. and globally. Roughly 250 million people are affected by knee OA worldwide, and about 14…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences